Gartner (IT) Competitors $359.64 -13.64 (-3.65%) Closing price 07/15/2025 03:59 PM EasternExtended Trading$359.28 -0.35 (-0.10%) As of 07/15/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock IT vs. CCRN, DOCU, FORR, GOOG, ICFI, ACN, APTV, TRU, TT, and CTSHShould you be buying Gartner stock or one of its competitors? The main competitors of Gartner include Cross Country Healthcare (CCRN), Docusign (DOCU), Forrester Research (FORR), Alphabet (GOOG), ICF International (ICFI), Accenture (ACN), Aptiv (APTV), TransUnion (TRU), Trane Technologies (TT), and Cognizant Technology Solutions (CTSH). Gartner vs. Its Competitors Cross Country Healthcare Docusign Forrester Research Alphabet ICF International Accenture Aptiv TransUnion Trane Technologies Cognizant Technology Solutions Gartner (NYSE:IT) and Cross Country Healthcare (NASDAQ:CCRN) are both business services companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, valuation, institutional ownership, media sentiment and risk. Do analysts prefer IT or CCRN? Gartner currently has a consensus target price of $513.67, suggesting a potential upside of 42.83%. Cross Country Healthcare has a consensus target price of $17.93, suggesting a potential upside of 48.67%. Given Cross Country Healthcare's higher probable upside, analysts clearly believe Cross Country Healthcare is more favorable than Gartner.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Gartner 1 Sell rating(s) 3 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.44Cross Country Healthcare 0 Sell rating(s) 6 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has stronger earnings and valuation, IT or CCRN? Gartner has higher revenue and earnings than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than Gartner, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGartner$6.30B4.39$1.25B$16.0722.38Cross Country Healthcare$1.34B0.29-$14.56M-$0.53-22.75 Which has more volatility & risk, IT or CCRN? Gartner has a beta of 1.19, meaning that its share price is 19% more volatile than the S&P 500. Comparatively, Cross Country Healthcare has a beta of 0.36, meaning that its share price is 64% less volatile than the S&P 500. Does the media prefer IT or CCRN? In the previous week, Gartner had 36 more articles in the media than Cross Country Healthcare. MarketBeat recorded 38 mentions for Gartner and 2 mentions for Cross Country Healthcare. Gartner's average media sentiment score of 0.67 beat Cross Country Healthcare's score of 0.63 indicating that Gartner is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Gartner 19 Very Positive mention(s) 3 Positive mention(s) 12 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Positive Cross Country Healthcare 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals hold more shares of IT or CCRN? 91.5% of Gartner shares are owned by institutional investors. Comparatively, 96.0% of Cross Country Healthcare shares are owned by institutional investors. 3.6% of Gartner shares are owned by company insiders. Comparatively, 4.9% of Cross Country Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Is IT or CCRN more profitable? Gartner has a net margin of 19.82% compared to Cross Country Healthcare's net margin of -1.41%. Gartner's return on equity of 96.70% beat Cross Country Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets Gartner19.82% 96.70% 13.68% Cross Country Healthcare -1.41%2.56%1.84% SummaryGartner beats Cross Country Healthcare on 13 of the 16 factors compared between the two stocks. Get Gartner News Delivered to You Automatically Sign up to receive the latest news and ratings for IT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IT vs. The Competition Export to ExcelMetricGartnerConsulting IndustryBusiness SectorNYSE ExchangeMarket Cap$28.73B$7.64B$15.10B$20.84BDividend YieldN/A1.66%2.73%3.65%P/E Ratio22.3824.8327.9227.17Price / Sales4.393.0842.0848.23Price / Cash22.0517.8926.2622.28Price / Book20.476.046.304.56Net Income$1.25B$272.15M$195.98M$995.22M7 Day Performance-8.64%-0.23%-1.01%-1.16%1 Month Performance-12.06%2.01%3.49%3.18%1 Year Performance-22.84%-7.61%21.44%6.83% Gartner Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ITGartner4.6201 of 5 stars$359.64-3.7%$513.67+42.8%-21.0%$28.73B$6.30B22.3821,044Trending NewsAnalyst ForecastHigh Trading VolumeCCRNCross Country Healthcare3.8347 of 5 stars$12.75-2.0%$17.93+40.6%-14.3%$417.95M$1.34B-24.068,205DOCUDocusign4.7688 of 5 stars$77.64-1.7%$89.77+15.6%+32.6%$15.69B$2.98B14.686,838Positive NewsFORRForrester Research4.2721 of 5 stars$10.53-2.8%N/A-46.2%$200.70M$432.47M-2.301,571GOOGAlphabet4.8671 of 5 stars$177.56-1.7%$206.38+16.2%-2.7%$2.15T$350.02B19.79190,200Trending NewsUpcoming EarningsICFIICF International4.4467 of 5 stars$88.390.0%$127.20+43.9%-36.4%$1.63B$2.01B15.169,300ACNAccenture4.9895 of 5 stars$300.48-1.4%$370.71+23.4%-13.1%$188.20B$64.90B23.92774,000Positive NewsInsider TradeAPTVAptiv4.8926 of 5 stars$71.96-0.8%$81.61+13.4%-4.1%$15.67B$19.71B11.91141,000Positive NewsAnalyst ForecastTRUTransUnion4.3333 of 5 stars$91.55-0.1%$109.69+19.8%+11.7%$17.86B$4.18B48.7013,400Positive NewsTTTrane Technologies4.4099 of 5 stars$434.11-0.7%$430.13-0.9%+28.0%$96.82B$19.84B36.1245,000Positive NewsAnalyst ForecastCTSHCognizant Technology Solutions4.8543 of 5 stars$80.46-0.6%$85.00+5.6%+2.6%$39.66B$19.74B16.94336,800Positive News Related Companies and Tools Related Companies CCRN Alternatives DOCU Alternatives FORR Alternatives GOOG Alternatives ICFI Alternatives ACN Alternatives APTV Alternatives TRU Alternatives TT Alternatives CTSH Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:IT) was last updated on 7/16/2025 by MarketBeat.com Staff From Our Partners3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gartner, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Gartner With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.